Health Care & Life Sciences » Biotechnology | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. | Cash Flow

Fiscal year is January-December. All values HKD Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
125
161
180
176
81
169
Depreciation, Depletion & Amortization
20
32
35
35
52
66
Other Funds
280
-
-
-
-
2,222
Funds from Operations
126
165
187
177
1,976
2,458
Changes in Working Capital
13
54
68
13
60
23
Net Operating Cash Flow
113
111
119
164
1,916
2,435
Capital Expenditures
78
62
63
64
74
Sale of Fixed Assets & Businesses
2
1
17
7
7
Purchase/Sale of Investments
3
9
11
8
1,869
Net Investing Cash Flow
74
53
62
49
1,935
Cash Dividends Paid - Total
-
-
57
33
53
Issuance/Reduction of Debt, Net
109
19
111
6
23
Net Financing Cash Flow
171
19
54
39
30
Net Change in Cash
210
39
111
76
50
Free Cash Flow
41
56
72
110
1,852
Net Assets from Acquisitions
-
-
28
-
-
Exchange Rate Effect
-
-
-
-
-

About Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.

View Profile
Address
Zhangjiang Hi-Tech Park
Shanghai Shanghai 201210
China
Employees -
Website http://www.fd-zj.com
Updated 07/08/2019
Shanghai Fudan Zhangjiang Bio Pharmaceutical Co. Ltd. engages in medical development. The company's activities include research and development, as well as commercialization of innovative drugs. It engages in genetic technical platform, photodynamic platform, nano technical platform and diagnosis technology platform.